321 Preclinical potency assessment of SynKIR-110, a mesothelin-specific KIR-CAR T cell therapy for mesothelioma

321 Preclinical potency assessment of SynKIR-110, a mesothelin-specific KIR-CAR T cell therapy for mesothelioma

Bibliographic Details
Main Authors:	Selene Nunez-Cruz, Michael Milone, Jun Xu, Laura Johnson, Jacqueline Rivera
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
by: Laura Castelletti, et al.
Published: (2021-02-01)

Discovery, characterization and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for Kir2.3, Kir3.X and Kir7.1
by: Jerod S Denton
Published: (2011-11-01)

Differential pH sensitivity of Kir4.1 and Kir4.2 and their modulation by heteropolymerisation with Kir5.1
by: Pessia, M, et al.
Published: (2001)

Inhibitory effect of terfenadine on Kir2.1 and Kir2.3 channels
by: Delgado-Ramírez Mayra, et al.
Published: (2021-06-01)

Differential pH sensitivity of Kir4.1 and Kir4.2 potassium channels and their modulation by heteropolymerisation with Kir5.1.
by: Pessia, M, et al.
Published: (2001)

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
by: David J. Margolis, et al.
Published: (2023-01-01)

KIR2DL2, KIR2DL5A and KIR2DL5B genes induce susceptibility to dengue virus infection while KIR3DL3 and KIR2DS5 confers protection
by: Aziz Sidi Aristide TAPSOBA, et al.
Published: (2022-10-01)

KIR2DL2, KIR2DL5A and KIR2DL5B genes induce susceptibility to dengue virus infection while KIR3DL3 and KIR2DS5 confers protection
by: Aziz Sidi Aristide TAPSOBA, et al.
Published: (2022-10-01)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts.
by: Gamze Isitman, et al.
Published: (2016-01-01)

Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3.
by: Chrissy H Roberts, et al.
Published: (2014-03-01)

Kir5.1 underlies long-lived subconductance levels in heteromeric Kir4.1/Kir5.1 channels from Xenopus tropicalis.
by: Shang, L, et al.
Published: (2009)

Identification of mutations in Kir5.1 which affect time-dependent activation of heteromeric Kir4.1/Kir5.1 potassium channels
by: Tucker, S, et al.
Published: (2002)

No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis.
by: McCappin, J, et al.
Published: (2010)

The KIRs of HLA-B27: the role of HLA-B27 KIR interactions in infection and spondyloarthritis
by: Wong-Baeza, I, et al.
Published: (2011)

Glimepiride block of Kir6.2/SUR1 Kir6.2/SUR2A and Kir6.2/SUR2A and Kir6.2/SUR2B K-ATP channels.
by: Ashcroft, F, et al.
Published: (2001)

Identification of domains that control the heteromeric assembly of Kir5.1/Kir4.0 potassium channels.
by: Konstas, A, et al.
Published: (2003)

INWARDLY RECTIFYING K+ CURRENTS IN OOCYTES CO-EXPRESSING KIR3.1 AND KIR3.2
by: Ammala, C, et al.
Published: (1995)

Nomenclature for the KIR of non-human species
by: Robinson, J, et al.
Published: (2018)

Extensive Alternative Splicing of KIR Transcripts
by: Jesse Bruijnesteijn, et al.
Published: (2018-12-01)

Preclinical Insights into the Role of Kir4.1 in Chronic Pain and Depression: Mechanisms and Therapeutic Potential
by: Tingfeng Zha, et al.
Published: (2025-01-01)

EAST/SeSAME Syndrome and Beyond: The Spectrum of Kir4.1- and Kir5.1-Associated Channelopathies
by: Jacky Lo, et al.
Published: (2022-03-01)

Codon Harmonization of a Kir3.1-KirBac1.3 Chimera for Structural Study Optimization
by: Evan Van Aalst, et al.
Published: (2020-03-01)

Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
by: Shoeib Moradi, et al.
Published: (2021-04-01)

Lack of association of KIR3DL1 or KIR3DS1 with ankylosing spondylitis in a UK population
by: Harvey, D, et al.
Published: (2007)

KIR And HLA Haplotype Analysis in a Family Lacking The KIR 2DL1-2DP1 Genes
by: Vojvodić Svetlana, et al.
Published: (2015-06-01)

Characterization of mesothelin gene expression in dogs and overexpression in canine mesotheliomas
by: Rina Nabeta, et al.
Published: (2024-09-01)

Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel.
by: Reimann, F, et al.
Published: (2001)

Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure
by: Raquel Morales, et al.
Published: (2023-03-01)

KIR- Ligand Interactions in Hypertensive Disorders in Pregnancy
by: Katarzyna Stefańska, et al.
Published: (2022-07-01)

HLA-KIR Interactions and Immunity to Viral Infections
by: Masoud Sabouri Ghannad, et al.
Published: (2014-02-01)

The role of KIR genes and ligands in leukemia surveillance
by: Florian eBabor, et al.
Published: (2013-02-01)

Non-equivalent role of TM2 gating hinges in heteromeric Kir4.1/Kir5.1 potassium channels.
by: Shang, L, et al.
Published: (2008)

Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
by: Tammaro, P, et al.
Published: (2005)

Inhibition of Cardiac Kir Current (IK1) by Protein Kinase C Critically Depends on PKCβ and Kir2.2.
by: Daniel Scherer, et al.
Published: (2016-01-01)

Calcineurin inhibitors stimulate Kir4.1/Kir5.1 of the distal convoluted tubule to increase NaCl cotransporter
by: Dan-Dan Zhang, et al.
Published: (2023-04-01)

Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma
by: Beatrice M. Muriuki, et al.
Published: (2023-01-01)

Breaking through the treatment desert of conventional mesothelin-targeted CAR-T cell therapy for malignant mesothelioma: A glimpse into the future
by: Yuning Wang, et al.
Published: (2024-06-01)

No association of KIR3DL1 or KIR3DS1 or their alleles with ankylosing spondylitis (vol 75, pg 68, 2009)
by: McCappin, J, et al.
Published: (2011)

Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.
by: Kouyuki Hirayasu, et al.
Published: (2012-01-01)

Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome.
by: Jose Ramón Vidal-Castiñeira, et al.
Published: (2014-01-01)